Stephen A. Trowbridge - 19 Jul 2025 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
EVP and CFO
Signature
/s/ Lawrence T. Weiss, Attorney in Fact
Issuer symbol
ANGO
Transactions as of
19 Jul 2025
Net transactions value
-$34,691
Form type
4
Filing time
22 Jul 2025, 18:22:23 UTC
Previous filing
18 Jul 2025
Next filing
14 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Trowbridge Stephen A EVP and CFO 14 PLAZA DRIVE, LATHAM /s/ Lawrence T. Weiss, Attorney in Fact 22 Jul 2025 0001624250

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Tax liability $22,464 -2,585 -1% $8.69 257,123 19 Jul 2025 Direct F1
transaction ANGO Common Stock Tax liability $6,231 -717 -0.28% $8.69 256,406 20 Jul 2025 Direct F2
transaction ANGO Common Stock Tax liability $5,996 -667 -0.26% $8.99 255,739 21 Jul 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exempt disposition of 2,585 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023.
F2 The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
F3 The exempt disposition of 667 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021.